LAPTM4B and colorectal carcinoma: Prior studies by the CRC Subtyping Consortium defined four consensus molecular subtypes (CMSs) [17], with LAPTM4B being lowest in CMS1 (predominantly MSI‐enriched) and highest in CMS2 and CMS4, both characterized by high chromosomal instability (p < 0.0001; Figure S4F).